Citi initiates coverage on Bristol-Myers Squibb (NYSE: BMY) with a Neutral. Price target $23.

Citi analyst says, "We ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE